MapLight Therapeutics (MPLT) PT Raised to $36 at Stifel
Tweet Send to a Friend
Stifel analyst Paul Matteis raised the price target on MapLight Therapeutics (NASDAQ: MPLT) to $36.00 (from $28.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
